| Safeway Pharmacy #1078 | |
| 2930 Ocean Beach Hwy, Longview, Washington 98632 | |
| (360) 575-6246 |
| Name | Safeway Pharmacy #1078 |
|---|---|
| Organization Name | Safeway Inc |
| Location | 2930 Ocean Beach Hwy, Longview, Washington 98632 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (360) 575-6246 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
During the COVID-19 pandemic, health care professionals and researchers have been confined mostly to using local and national datasets to study the impact of comorbidities, pre-existing medication use, demographics and various interventions on disease course.
How U.S. Hispanic/Latino adults perceive their own social standing, relative to the general population may be an important factor contributing to their overall cardiovascular health, according to new research published today in the Journal of the American Heart Association, an open-access journal of the American Heart Association.
Ziehm Imaging's intuitive SmartVascular software considerably simplifies imaging in vascular surgery. It introduces an entirely new workflow for fast results. This solution raises efficiency levels, eliminates interim C-arm operating steps and automates the imaging processes. SmartVascular is compatible with all Ziehm Vision C-arms and tailored to vascular procedures.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, today announced the full exercise of the over-allotment option granted to the underwriters to purchase an additional 862,500 shares of its common stock and warrants to purchase an additional 431,250 shares (15% of the shares and warrants sold in this offering), at a public offering price of $4.00 per share and $0.001 per warrant, respectively, in connection with its previously announced underwritten public offering of 5,750,000 shares of common stock, and warrants to purchase up to an aggregate of 2,875,000 shares of common stock, bringing the total gross proceeds from the offering to approximately $26,500,000, before deducting underwriting discounts and commissions and other offering expenses payable by Advaxis, Inc.
› Verified 5 days ago
| NPI Number | 1881625689 |
| Organization Name | SAFEWAY INC |
| Doing Business As | SAFEWAY PHARMACY #1078 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 2930 Ocean Beach Hwy, Longview, WA 98632 |
| Phone Number | 360-575-6246 |
News Archive
During the COVID-19 pandemic, health care professionals and researchers have been confined mostly to using local and national datasets to study the impact of comorbidities, pre-existing medication use, demographics and various interventions on disease course.
How U.S. Hispanic/Latino adults perceive their own social standing, relative to the general population may be an important factor contributing to their overall cardiovascular health, according to new research published today in the Journal of the American Heart Association, an open-access journal of the American Heart Association.
Ziehm Imaging's intuitive SmartVascular software considerably simplifies imaging in vascular surgery. It introduces an entirely new workflow for fast results. This solution raises efficiency levels, eliminates interim C-arm operating steps and automates the imaging processes. SmartVascular is compatible with all Ziehm Vision C-arms and tailored to vascular procedures.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, today announced the full exercise of the over-allotment option granted to the underwriters to purchase an additional 862,500 shares of its common stock and warrants to purchase an additional 431,250 shares (15% of the shares and warrants sold in this offering), at a public offering price of $4.00 per share and $0.001 per warrant, respectively, in connection with its previously announced underwritten public offering of 5,750,000 shares of common stock, and warrants to purchase up to an aggregate of 2,875,000 shares of common stock, bringing the total gross proceeds from the offering to approximately $26,500,000, before deducting underwriting discounts and commissions and other offering expenses payable by Advaxis, Inc.
› Verified 5 days ago
News Archive
During the COVID-19 pandemic, health care professionals and researchers have been confined mostly to using local and national datasets to study the impact of comorbidities, pre-existing medication use, demographics and various interventions on disease course.
How U.S. Hispanic/Latino adults perceive their own social standing, relative to the general population may be an important factor contributing to their overall cardiovascular health, according to new research published today in the Journal of the American Heart Association, an open-access journal of the American Heart Association.
Ziehm Imaging's intuitive SmartVascular software considerably simplifies imaging in vascular surgery. It introduces an entirely new workflow for fast results. This solution raises efficiency levels, eliminates interim C-arm operating steps and automates the imaging processes. SmartVascular is compatible with all Ziehm Vision C-arms and tailored to vascular procedures.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, today announced the full exercise of the over-allotment option granted to the underwriters to purchase an additional 862,500 shares of its common stock and warrants to purchase an additional 431,250 shares (15% of the shares and warrants sold in this offering), at a public offering price of $4.00 per share and $0.001 per warrant, respectively, in connection with its previously announced underwritten public offering of 5,750,000 shares of common stock, and warrants to purchase up to an aggregate of 2,875,000 shares of common stock, bringing the total gross proceeds from the offering to approximately $26,500,000, before deducting underwriting discounts and commissions and other offering expenses payable by Advaxis, Inc.
› Verified 5 days ago
Cascade Eye Care Ps Type: Medicare Supplier Location: 950 11th Ave, Longview, Washington 98632 Phone: (360) 577-1500 | |
Evergreen Prosthetics And Orthotics Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1555 3rd Ave, Longview, Washington 98632 Phone: (360) 232-8525 | |
Fred Meyer Pharmacy #185 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3184 Ocean Beach Hwy, Longview, Washington 98632 Phone: (360) 425-6222 | |
Hanger Clinic Type: Prosthetic/Orthotic Supplier Location: 1516 Hudson St, Longview, Washington 98632 Phone: (360) 423-6049 | |
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1030 Columbia Blvd, Longview, Washington 98632 Phone: (360) 423-1900 |